HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
396.67
-8.02 (-1.98%)
At close: May 20, 2026, 4:00 PM EDT
398.91
+2.24 (0.57%)
After-hours: May 20, 2026, 7:47 PM EDT
HCA Healthcare Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, HCA Healthcare stock has a consensus rating of "Buy" and an average price target of $510.95. The average 1-year stock price forecast is 28.81% higher than the current stock price, while the lowest is $396 (-0.17%) and the highest is $635 (+60.08%).
Price Target: $510.95 (+28.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 | 6 | 6 |
| Buy | 7 | 6 | 6 | 6 | 7 | 7 |
| Hold | 7 | 7 | 7 | 7 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 21 | 21 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $561 → $500 | Strong Buy | Maintains | $561 → $500 | +26.05% | Apr 27, 2026 |
| Barclays | Barclays | Buy Maintains $551 → $496 | Buy | Maintains | $551 → $496 | +25.04% | Apr 27, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $593 → $534 | Buy | Maintains | $593 → $534 | +34.62% | Apr 27, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $481 → $436 | Hold | Maintains | $481 → $436 | +9.92% | Apr 27, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $560 → $530 | Buy | Maintains | $560 → $530 | +33.61% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
79.42B
from 75.60B
Increased by 5.05%
Revenue Next Year
83.21B
from 79.42B
Increased by 4.77%
EPS This Year
30.53
from 28.33
Increased by 7.77%
EPS Next Year
33.59
from 30.53
Increased by 10.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 83.8B | 88.6B | ||||||
| Avg | 79.4B | 83.2B | ||||||
| Low | 76.1B | 79.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.8% | 11.6% | ||||||
| Avg | 5.1% | 4.8% | ||||||
| Low | 0.6% | 0.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 33.35 | 36.25 | ||||||
| Avg | 30.53 | 33.59 | ||||||
| Low | 28.52 | 31.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 17.7% | 18.7% | ||||||
| Avg | 7.8% | 10.0% | ||||||
| Low | 0.7% | 2.3% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.